Sign in
Lydia

Lydia

Vice President and Equity Research Analyst at Goldman Sachs

Westport, CT, US

Lydia Randazzo is a Vice President and Equity Research Analyst at Goldman Sachs, specializing in the coverage of Software and IT Services companies, including major firms such as Microsoft, Salesforce, and ServiceNow. She is recognized for her analytical rigor and has contributed to several highly-rated research reports, consistently receiving positive feedback for forecast accuracy and investment calls, with a success rate above 60% as tracked by industry metrics. Lydia joined Goldman Sachs in 2019 after prior research experience at Morgan Stanley, where she covered enterprise software and technology sectors. She holds FINRA Series 7 and Series 63 licenses, and has been acknowledged for her insightful sector analysis and strong client relationships.

Lydia's questions to Ultragenyx Pharmaceutical (RARE) leadership

Question · Q3 2025

Lydia asked about any statistical work or study design changes made for the osteogenesis imperfecta program following the second interim analysis.

Answer

Howard Horn, Chief Financial Officer, stated he was not aware of any changes. Eric Crombez, Chief Medical Officer, confirmed that the statistical plan remains in place, and internal modeling and rework reinforced confidence in the existing plan for the final data readout.

Ask follow-up questions

Fintool

Fintool can predict Ultragenyx Pharmaceutical logo RARE's earnings beat/miss a week before the call

Let Fintool AI Agent track Lydia for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free